Anti-Flt1 Peptide

Ref. 3D-PP46285

Produktinformation

• Name: Anti-Flt1 Peptide
• Synonyme: H-GNQWFI-OH

Beschreibung

Peptide Anti-Flt1 Peptide is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Anti-Flt1 Peptide include the following: Distinct roles of vascular endothelial growth factor receptor-1-and receptor-2-mediated signaling in T cell priming and Th17 polarization to lipopolysaccharide YS Kim, SJ Choi , YM Tae, BJ Lee, SG Jeon - The Journal of , 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/185/9/5648/83201 Target Specific and Long-Acting Delivery of Biopharmaceuticals Using Hyaluronic Acid Derivatives SK Hahn , EJ Oh, K Park , KS Kim, JA Yang - abstracts.biomaterials.orghttps://abstracts.biomaterials.org/data/papers/2010/897.pdf Anti-Flt1 peptide and cyanine-conjugated gold nanoparticles for the concurrent antiangiogenic and endothelial cell proton treatment SJ Seo, SH Lee, KH Kim, JK Kim - Journal of Biomedical , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jbm.b.34220 Two-photon microscopy of a Flt1 peptide-hyaluronate conjugate S Beack , JS Choi, JH Lee, H Kim , KH Kim , CK Joo - , 2015 - Future Medicinehttps://www.futuremedicine.com/doi/abs/10.2217/nnm.15.71 Vascular Endothelial Growth Factor Receptor 1 Targeting Fusion Polypeptides with Stimuli-Responsiveness for Anti-angiogenesis MJ Kang, KH Roh, JS Lee, JH Lee - Applied Materials & , 2023 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acsami.3c03989 Tc-99m and fluorescence-labeled anti-flt1 peptide as a multimodal tumor imaging agent targeting vascular endothelial growth factor-receptor 1 MH Kim, SG Kim, DW Kim - Nuclear Medicine and Molecular Imaging, 2018 - Springerhttps://link.springer.com/article/10.1007/s13139-018-0535-8 Inhibition of FLT1 ameliorates muscular dystrophy phenotype by increased vasculature in a mouse model of Duchenne muscular dystrophy M Verma , Y Shimizu-Motohashi, Y Asakura - PLoS , 2019 - journals.plos.orghttps://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1008468 Developing antiangiogenic peptide drugs for angiogenesis-related diseases KN Sulochana , R Ge - Current pharmaceutical design, 2007 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2007/00000013/00000020/art00005 Hyaluronate-Flt1 peptide conjugate/epirubicin micelles for theranostic application to liver cancers K SuaKim, S WooaHong, S HyunaYun, S KewaYoon - Rsc Advances, 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/ra/c5ra07464a Decreased efficacy of drugs targeting the vascular endothelial growth factor pathway by the epigenetic silencing of FLT1 in renal cancer cells JY Kim, J Hwang, SH Lee, HJ Lee , J Jelinek - Clinical , 2015 - Springerhttps://link.springer.com/article/10.1186/s13148-015-0134-9 The Effect of Anti-Flt1 Peptide-Hyaluronate Conjugate for the Treatment of Corneal Neovascularization JS Choi, SY Shin, S Hahn - Ophthalmology & Visual , 2010 - iovs.arvojournals.orghttps://iovs.arvojournals.org/article.aspx?articleid=2374300 Flt1 peptide-hyaluronate conjugate micelle-like nanoparticles encapsulating genistein for the treatment of ocular neovascularization H Kim , JS Choi, KS Kim , JA Yang, CK Joo, SK Hahn - Acta biomaterialia, 2012 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1742706112003170 Bioimaging and pulmonary applications of self-assembled Flt1 peptide-hyaluronic acid conjugate nanoparticles H Kim , HT Park, YM Tae, WH Kong , DK Sung - Biomaterials, 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961213008600 Bioimaging and Pulmonary Applications of Flt1 peptide-Hyaluronate Conjugate Nanoparticles H Kim , HT Park, YM Tae, WH Kong , DK Sung - abstracts.biomaterials.orghttp://abstracts.biomaterials.org/data/papers/2014/0332-000372.pdf Synthesis, characterization, and preliminary assessment of anti-Flt1 peptide-hyaluronate conjugate for the treatment of corneal neovascularization EJ Oh, K Park , JS Choi, CK Joo, SK Hahn - Biomaterials, 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961209007480 Anti-Flt1 peptide-hyaluronate conjugate for the treatment of retinal neovascularization and diabetic retinopathy EJ Oh, JS Choi, H Kim , CK Joo, SK Hahn - Biomaterials, 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0142961211000044 Anti-Flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis DG Bae, TD Kim, G Li, WH Yoon, CB Chae - Clinical cancer research, 2005 - AACRhttps://aacrjournals.org/clincancerres/article-abstract/11/7/2651/188204 Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 A Sadremomtaz , K Mansouri , G Alemzadeh - et Biophysica Acta (BBA , 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0304416518302794 Short peptides interfering with signaling pathways as new therapeutic tools for cancer treatment A Ellert-Miklaszewska, K Poleszak - Future Medicinal , 2017 - Future Sciencehttps://www.future-science.com/doi/abs/10.4155/fmc-2016-0189

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 763.86 g/mol
• Formel: C₃₇H₄₉N₉O₉